{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Mary+Glindon&answer.answeringMember.label=Biography+information+for+George+Freeman", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?tablingMemberPrinted.=Mary+Glindon&answer.answeringMember.label=Biography+information+for+George+Freeman", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Mary+Glindon&_metadata=all&answer.answeringMember.label=Biography+information+for+George+Freeman", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Mary+Glindon&_page=0&answer.answeringMember.label=Biography+information+for+George+Freeman", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Mary+Glindon&answer.answeringMember.label=Biography+information+for+George+Freeman", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Mary+Glindon&answer.answeringMember.label=Biography+information+for+George+Freeman", "items" : [{"_about" : "http://data.parliament.uk/resources/1386996", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1386996/answer", "answerText" : {"_value" : "<p>VMIC was a project set up in the 2017 Life Sciences Sector Deal to support UK leadership in next generation vaccine manufacturing technology. The pandemic has dramatically accelerated both the demand and the technology of vaccine production since VMIC was established. The Government has invested over £380 million to secure and scale-up the UK\u2019s manufacturing capabilities to be able to respond to this pandemic, as well as any future pandemics, and in support of vaccine innovation at numerous facilities across the UK. Our positive engagement with industry and the UK\u2019s strong science base and international reputation has also seen a number of private investments across the whole of the UK announced over the past year. These include Serum Institute of India\u2019s £50m investment into Oxford Biomedica, Thermo Fisher Scientific\u2019s £70m expansion of its Swindon site and Fujifilm\u2019s £400m investment into its Billingham, Teesside facility.<\/p><p>One such facility that the Government provided support to is the Vaccine Manufacturing Innovation Centre (VMIC) which has the potential to be a significant part of the UK vaccine manufacturing ecosystem. VMIC is a private company, limited by guarantee, and as such the UK Government does not exercise any ownership rights.<\/p><p>Officials are working closely with VMIC and other third parties to ensure that the UK retains a strong domestic vaccine manufacturing capability to contribute to our response to COVID-19 and resilience to other future health emergencies. We will ensure that the UK\u2019s vaccine capabilities continue to benefit from the public investment. Discussions are commercially sensitive between VMIC and private potential acquirers.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
        }
        , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
        , "answeringMemberPrinted" : {"_value" : "George Freeman"}
        , "dateOfAnswer" : {"_value" : "2021-12-16", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1386996/answer/previousversion/39501", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
          }
          , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
          , "answeringMemberPrinted" : {"_value" : "George Freeman"}
        }
        , "questionFirstAnswered" : [{"_value" : "2021-12-16T10:16:16.677Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "201"}
      , "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"}
      , "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"}
      , "date" : {"_value" : "2021-12-10", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Vaccine Manufacturing and Innovation Centre"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Business, Energy and Industrial Strategy, for what reason the Government is selling the Vaccine Manufacturing and Innovation Centre.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4126", "label" : {"_value" : "Biography information for Mary Glindon"}
      }
      , "tablingMemberConstituency" : {"_value" : "North Tyneside"}
      , "tablingMemberPrinted" : [{"_value" : "Mary Glindon"}
      ], "uin" : "90873"}
    , {"_about" : "http://data.parliament.uk/resources/353919", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/353919/answer", "answerText" : {"_value" : "<p>A wide range of research relating to stem cell transplantation is supported by the Department through the National Institute for Health Research (NIHR). The translation of scientific advances to the clinic is supported through NIHR Biomedical Research Centres and Units, clinical research facilities and experimental cancer medicine centres (funded jointly with Cancer Research UK). The NIHR clinical research network supports the coordination of clinical trials including any involving stem cell transplantation. NHS Blood and Transplant are directly involved in a number of research projects and provide an essential part of the necessary infrastructure supporting research in this field. NHS England supports the important role of innovation and research in transforming the quality of services.<\/p><p> <\/p><p> <\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
        }
        , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
        , "answeringMemberPrinted" : {"_value" : "George Freeman"}
        , "dateOfAnswer" : {"_value" : "2015-06-19", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2015-06-19T11:09:08.017Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2015-06-12", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Stem Cells: Research"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health, what steps his Department is taking to support scientific research into stem cell transplantation.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4126", "label" : {"_value" : "Biography information for Mary Glindon"}
      }
      , "tablingMemberConstituency" : {"_value" : "North Tyneside"}
      , "tablingMemberPrinted" : [{"_value" : "Mary Glindon"}
      ], "uin" : "2328"}
    , {"_about" : "http://data.parliament.uk/resources/353920", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/353920/answer", "answerText" : {"_value" : "<p>NHS England expects to publish its response to the Investing in Specialised Services consultation by the end of June 2015.<\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
        }
        , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
        , "answeringMemberPrinted" : {"_value" : "George Freeman"}
        , "dateOfAnswer" : {"_value" : "2015-06-19", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2015-06-19T10:58:35.283Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2015-06-12", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "NHS England: Public Consultation"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health, when he expects NHS England to respond to its consultation on Investing in Specialised Services.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4126", "label" : {"_value" : "Biography information for Mary Glindon"}
      }
      , "tablingMemberConstituency" : {"_value" : "North Tyneside"}
      , "tablingMemberPrinted" : [{"_value" : "Mary Glindon"}
      ], "uin" : "2329"}
    , {"_about" : "http://data.parliament.uk/resources/348294", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/348294/answer", "answerText" : {"_value" : "<p>NHS England has advised that there were 35 online responses received during the 30 day consultation period.<\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
        }
        , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
        , "answeringMemberPrinted" : {"_value" : "George Freeman"}
        , "dateOfAnswer" : {"_value" : "2015-06-12", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2015-06-12T10:52:01.34Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2015-06-03", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Co-careldopa"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health, how many submissions NHS England has received on the consultation on Duodopa levodopa-carbidopa intestinal gel clinical commissioning policy.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4126", "label" : {"_value" : "Biography information for Mary Glindon"}
      }
      , "tablingMemberConstituency" : {"_value" : "North Tyneside"}
      , "tablingMemberPrinted" : [{"_value" : "Mary Glindon"}
      ], "uin" : "980"}
    ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 4, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}